Menu

CDC Director Delivers Passionate Speech to Agency

Robert Redfield emphasized the importance of science and data in meeting with employees.

Mar 30, 2018
Jim Daley

JAMES GATHANY, WIKIMEDIA

Robert Redfield, the newly appointed director of the Centers for Disease Control and Prevention (CDC), delivered an emotional address to agency members Thursday (March 29) in which he said he was honored to lead the best “science-based, data-driven agency in the world,” reports the The Washington Post. During his remarks he frequently emphasized the importance of science and data, saying they are the reason for the agency’s credibility. According to the Post, the speech was well received by agency employees.

In January, top CDC officials reportedly instructed employees to avoid using seven words in budget documents, including “evidence-based” and “science-based.” That same month, Brenda Fitzgerald resigned as director of the agency after less than a year in the position because of financial conflicts of interest. Redfield did not address either issue in his remarks.

See “Federal Officials and Scientists Respond to Purported CDC Word Ban

Redfield, who took the helm of the CDC last week, also vowed to bring the opioid crisis “to its knees” (via The Republic). He said the AIDS epidemic could be ended in the U.S. “in the next three to seven years, if we put our mind to it,” according to STAT News.

In the address, Redfield called the opioid epidemic “the public health crisis of our time,” noting it is a medical, not a moral, issue, and saying the CDC would help direct the government’s response, The Washington Post reports. “If any of you have tried to access care for addiction in this nation, I can guarantee you it’s complicated,” he said.

See “AIDS Researcher Emerges as Top Candidate to Head CDC

Reactions to Redfield’s appointment from AIDS activists have been mixed. Sarah Kate Ellis, the president and CEO of the Gay & Lesbian Alliance Against Defamation (GLAAD), says in a March 21 Wall Street Journal article that “HIV advocates have pointed to Redfield’s record of promoting stigma and fear around HIV and AIDS and that should give us pause about this appointment.” In the same article Michael Ruppal, executive director of The AIDS Institute, says Redfield’s appointment “provides us with great optimism.”

In an opinion published March 23 in Foreign Policy, Laurie Garrett, a former Senior Fellow at the Council on Foreign Relations Global Health Program, calls Redfield “exactly the wrong person for the job.” She writes that Redfield’s record in HIV research “has been a scientific and moral failure,” citing his policy that mandated HIV testing for all troops in 1985, while he was a US Army major at the Walter Reed Army Institute of Research. Redfield was also involved in an unsuccessful attempt to require HIV testing of health-care professionals who perform invasive procedures in 1991, according to The Washington Post

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening